KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Amgen (AMGN) over the last 16 years, with Q3 2025 value amounting to 0.13%.

  • Amgen's Return on Capital Employed rose 400.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.1% for FY2024, which is 200.0% down from last year.
  • Latest data reveals that Amgen reported Return on Capital Employed of 0.13% as of Q3 2025, which was up 400.0% from 0.12% recorded in Q2 2025.
  • In the past 5 years, Amgen's Return on Capital Employed registered a high of 0.2% during Q3 2022, and its lowest value of 0.09% during Q2 2024.
  • Its 5-year average for Return on Capital Employed is 0.14%, with a median of 0.13% in 2023.
  • As far as peak fluctuations go, Amgen's Return on Capital Employed soared by 500bps in 2022, and later plummeted by -900bps in 2023.
  • Quarter analysis of 5 years shows Amgen's Return on Capital Employed stood at 0.15% in 2021, then soared by 31bps to 0.2% in 2022, then crashed by -47bps to 0.1% in 2023, then rose by 2bps to 0.11% in 2024, then increased by 21bps to 0.13% in 2025.
  • Its Return on Capital Employed stands at 0.13% for Q3 2025, versus 0.12% for Q2 2025 and 0.11% for Q1 2025.